BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30878689)

  • 1. [Treatment of uncomplicated pelvic inflammatory disease: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines].
    Verdon R
    Gynecol Obstet Fertil Senol; 2019 May; 47(5):418-430. PubMed ID: 30878689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pelvic inflammatory diseases: Microbiologic diagnosis - CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines].
    Cazanave C; de Barbeyrac B
    Gynecol Obstet Fertil Senol; 2019 May; 47(5):409-417. PubMed ID: 30878688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in managing pelvic inflammatory disease.
    Judlin P
    Curr Opin Infect Dis; 2010 Feb; 23(1):83-7. PubMed ID: 19935421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations and rationale for the treatment of pelvic inflammatory disease.
    Jaiyeoba O; Lazenby G; Soper DE
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):61-70. PubMed ID: 21171878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microbiologic basis of diagnosis and treatment of pelvic inflammatory disease].
    Quentin R; Verdon R
    J Gynecol Obstet Biol Reprod (Paris); 2012 Dec; 41(8):850-63. PubMed ID: 23140621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents.
    Petrina MAB; Cosentino LA; Wiesenfeld HC; Darville T; Hillier SL
    Anaerobe; 2019 Apr; 56():61-65. PubMed ID: 30753898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
    Judlin P; Thiebaugeorges O
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):177-9. PubMed ID: 19467767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of Mycoplasma genitalium and Trichomonas vaginalis Among Adolescents and Young Adults With Pelvic Inflammatory Disease: Results From the Tech-N Study.
    Trent M; Yusuf HE; Perin J; Anders J; Chung SE; Tabacco-Saeed L; Rowell J; Huettner S; Rothman R; Butz A; Gaydos CA
    Sex Transm Dis; 2020 Nov; 47(11):e47-e50. PubMed ID: 32569258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease.
    Haggerty CL
    Curr Opin Infect Dis; 2008 Feb; 21(1):65-9. PubMed ID: 18192788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of uncomplicated pelvic inflammatory disease].
    Bourret A; Fauconnier A; Brun JL
    J Gynecol Obstet Biol Reprod (Paris); 2012 Dec; 41(8):864-74. PubMed ID: 23142353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease.
    Haggerty CL; Taylor BD
    Infect Dis Obstet Gynecol; 2011; 2011():959816. PubMed ID: 22235165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing for Mycoplasma genitalium in pelvic inflammatory disease: A clinical audit.
    Beesley V; Thng C
    Aust N Z J Obstet Gynaecol; 2022 Dec; 62(6):826-829. PubMed ID: 36089701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic inflammatory disease (PID) from Chlamydia trachomatis versus PID from Neisseria gonorrhea: from clinical suspicion to therapy.
    De Seta F; Banco R; Turrisi A; Airoud M; De Leo R; Stabile G; Ceccarello M; Restaino S; De Santo D
    G Ital Dermatol Venereol; 2012 Oct; 147(5):423-30. PubMed ID: 23007248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia.
    Mitchell CM; Anyalechi GE; Cohen CR; Haggerty CL; Manhart LE; Hillier SL
    J Infect Dis; 2021 Aug; 224(12 Suppl 2):S29-S35. PubMed ID: 34396407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical experience with ofloxacin in the treatment of sexually transmitted diseases.
    Corrado ML
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1396-9. PubMed ID: 2031521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follow-up and counselling after pelvic inflammatory disease: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines].
    Ah-Kit X; Hoarau L; Graesslin O; Brun JL
    Gynecol Obstet Fertil Senol; 2019 May; 47(5):458-464. PubMed ID: 30878686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.
    Haggerty CL; Totten PA; Astete SG; Lee S; Hoferka SL; Kelsey SF; Ness RB
    Sex Transm Infect; 2008 Oct; 84(5):338-42. PubMed ID: 18445635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polymicrobial etiology of acute pelvic inflammatory disease and treatment regimens.
    Dodson MG; Faro S
    Rev Infect Dis; 1985; 7 Suppl 4():S696-702. PubMed ID: 3909326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2017 European guideline for the management of pelvic inflammatory disease.
    Ross J; Guaschino S; Cusini M; Jensen J
    Int J STD AIDS; 2018 Feb; 29(2):108-114. PubMed ID: 29198181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.